BDSX Biodesix Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: BDSX

Price (delayed)

$29.29

Market cap

$309.04M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.11

Enterprise value

$350.84M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 34
Highlights
BDSX's EPS is up by 44% year-on-year and by 21% since the previous quarter
The company's gross profit rose by 41% YoY and by 8% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.biodesix.com
Peers: NEO OPK

Key stats

What are the main financial stats of BDSX

BDSX stock price

How has the Biodesix stock price performed over time
Intraday
4.05%
1 week
2.56%
1 month
9.99%
1 year
262.5%
YTD
330.74%
QTD
29.89%

Financial performance

How have Biodesix's revenue and profit performed over time
Revenue
$102.94M
Gross profit
$84.93M
Operating income
-$20.61M
Net income
-$27.76M
Gross margin
82.5%
Net margin
-27%
The operating margin has surged by 55% year-on-year and by 23% since the previous quarter
BDSX's net margin is up by 50% YoY and by 19% QoQ
The company's gross profit rose by 41% YoY and by 8% QoQ
The company's operating income rose by 40% YoY and by 17% QoQ

Price vs fundamentals

How does BDSX's price correlate with its fundamentals

Growth

What is Biodesix's growth rate over time

Valuation

What is Biodesix stock price valuation
P/E
N/A
P/B
32.38
P/S
2.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.41
BDSX's EPS is up by 44% year-on-year and by 21% since the previous quarter
The price to sales (P/S) is 117% higher than the last 4 quarters average of 1.3 and 28% higher than the 5-year quarterly average of 2.2
Biodesix's revenue has increased by 34% YoY and by 7% QoQ

Efficiency

How efficient is Biodesix business performance
The ROE has shrunk by 192% YoY but it has soared by 62% QoQ
BDSX's ROS has soared by 57% year-on-year and by 23% since the previous quarter
BDSX's ROIC is up by 45% YoY and by 18% QoQ
BDSX's return on assets is up by 31% year-on-year and by 15% since the previous quarter

Dividends

What is BDSX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BDSX.

Financial health

How did Biodesix financials performed over time
The company's total assets is 11% higher than its total liabilities
Biodesix's quick ratio has increased by 38% YoY and by 6% from the previous quarter
The company's current ratio rose by 33% YoY
The debt to equity has dropped by 88% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.